Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population

American Journal of Kidney Diseases

Volumn 59, Issue 5, 2012, Pages 653-662

  Astor, Brad C ^a,b,c,d   Shafi, Tariq ^c   Hoogeveen, Ron C ^e,f   Matsushita, Kunihiro ^a,b   Ballantyne, Christie M ^e,f   Inker, Lesley A ^g   Coresh, Josef ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

trace protein; 2 microglobulin; Chronic kidney disease; cystatin C; estimated glomerular filtration rate; serum creatinine

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY DISEASE; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPOCALINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84859787086     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.11.042     Document Type: Article

References (31)

1. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
3. Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010;55(1):31-41.
4. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049-2060. (Pubitemid 40664306)
5. Astor BC, Levey AS, Stevens LA, Van LF, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20(10):2214-2222.
6. Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med. 2007;147(1):19-27. (Pubitemid 351664630)
7. Peralta CA, Katz R, Sarnak MJ, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011;22(1):147-155.
8. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
9. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652-660.
10. Kottgen A, Selvin E, Stevens LA, Levey AS, Van LF, Coresh J. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2008;51(3):385-394. (Pubitemid 351273481)
11. Giessing M. Beta-trace protein as indicator of glomerular filtration rate. Urology. 1999;54(5):940-941. (Pubitemid 29505605)
12. Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem. 1999;45(4):567-568. (Pubitemid 29165968)
13. Poge U, Gerhardt TM, Stoffel-Wagner B, et al. Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem. 2005;51(8):1531-1533. (Pubitemid 41060895)
14. Filler G, Priem F, Lepage N, et al. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002;48(5):729-736. (Pubitemid 34439104)
15. Woitas RP, Stoffel-Wagner B, Poege U, Schiedermaier P, Spengler U, Sauerbruch T. Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem. 2001;47(12):2179-2180. (Pubitemid 33108889)
16. Hoffmann A, Nimtz M, Conradt HS. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology. 1997;7(4):499-506. (Pubitemid 27246723)
17. Shinkai S, Chaves PH, Fujiwara Y, et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch Intern Med. 2008;168(2):200-206. (Pubitemid 351185888)
18. Spanaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von EA. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem. 2010;56(5):740-749.
19. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
20. National Heart Lung and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 7: Blood Collection and Processing. Bethesda, MD: National Heart, Lung and Blood Institute; 1987.
21. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766-772. (Pubitemid 46580250)
22. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years'experience. J Clin Epidemiol. 1996;49(2):223-233. (Pubitemid 26123934)
23. Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol. 2007;18(4):1307-1315. (Pubitemid 46536917)
24. Zellner A. An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. J Am Stat Assoc. 1962;57:348-368.
25. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11-21.
26. Levey AS, de Jong PE, Coresh J, et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28.
27. Melegos DN, Grass L, Pierratos A, Diamandis EP. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology. 1999;53(1):32-37. (Pubitemid 29016610)
28. White CA, Akbari A, Doucette S, et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem. 2007;53(11):1965-1968. (Pubitemid 350036043)
29. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum beta2-microglobulin as marker of GFR. Ren Fail. 2001;23(3-4):419-429. (Pubitemid 32692277)
30. Delgado J, Pratt G, Phillips N, et al. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate. Br J Haematol. 2009;145(6):801-805.
31. Canaud B, Assounga A, Flavier JL, et al. Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean? ASAIO Trans. 1988;34(4):923-929. (Pubitemid 19030610)